# Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

> **NCT04124198** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Christian von Buchwald** · enrollment: 138 (estimated)

## Conditions studied

- Oropharynx Cancer
- Oropharynx Squamous Cell Carcinoma
- Carcinoma, Squamous Cell
- Carcinoma
- Oropharyngeal Neoplasms
- Neoplasms, Squamous Cell
- Neoplasms, Glandular and Epithelial
- Neoplasms by Histologic Type
- Pharyngeal Neoplasms Malignant and Unspecified
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Neoplasms by Site
- Otorhinolaryngologic Diseases
- Pharyngeal Diseases
- Papillomavirus Infections
- Virus Diseases
- DNA Virus Infections
- Tumor Virus Infections
- Quality of Life

## Interventions

- **RADIATION:** Intensity-Modulated Radiation Therapy (IMRT)
- **DRUG:** Cisplatin
- **DRUG:** Nimorazole.
- **PROCEDURE:** Transoral Robotic Surgery (TORS) with neck dissection

## Key facts

- **NCT ID:** NCT04124198
- **Lead sponsor:** Christian von Buchwald
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2025-12-16
- **Final completion:** 2029-12
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124198, "Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04124198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*